NCT06948279

Brief Summary

The goal of this clinical trial is to compare two different approaches for removing large or multiple stones from the common bile duct in older adults with chronic diseases. The main questions it aims to answer are: Is it better to remove the stones immediately during the first endoscopic procedure? Or is it safer and more effective to place a temporary plastic stent first and remove the stones later? Researchers will compare these two approaches to see which one leads to better stone clearance and fewer complications. Participants will: Undergo an endoscopic procedure (ERCP) to treat their bile duct stones. Be randomly assigned to either have immediate stone removal or have a stent placed first, with stone removal scheduled 8-12 weeks later. Attend follow-up visits to monitor their recovery and check for complications. This study is being conducted at the National Liver Institute, Menoufia University, Egypt.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 29, 2025

Completed
Last Updated

May 6, 2025

Status Verified

January 1, 2025

Enrollment Period

2.1 years

First QC Date

April 21, 2025

Last Update Submit

May 1, 2025

Conditions

Keywords

CholedocholithiasisBile DuctERCPElderly

Outcome Measures

Primary Outcomes (1)

  • Rate of complete stone clearance

    complete removal of all detectable stones from the common bile duct without the need for additional procedures

    One month

Secondary Outcomes (1)

  • ERCP-related adverse events

    Three months

Study Arms (2)

Group A (Stent-first Approach)

ACTIVE COMPARATOR

Group A patients had a temporary plastic stent placed to facilitate bile drainage, with elective stone removal scheduled 8-12 weeks later.

Procedure: The endoscopic retrograde cholangiopancreatography (ERCP) with insertion of a plastic stent.

Group B (Stone Retrieval-first Approach)

PLACEBO COMPARATOR

In Group B, patients underwent immediate stone extraction attempts using conventional techniques such as basket, balloon, or mechanical lithotripsy as needed.

Procedure: The endoscopic retrograde cholangiopancreatography (ERCP) with immediate stone extraction attempts.

Interventions

A plastic stent was placed during the initial ERCP, with elective stone removal scheduled 8-12 weeks later.

Group A (Stent-first Approach)

Immediate ERCP for stone removal, utilizing conventional techniques such as basket, balloon, or mechanical lithotripsy as needed.

Group B (Stone Retrieval-first Approach)

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥ 65 years
  • Charlson Comorbidity Index (CCI) ≥ 3
  • Presence of large or multiple CBD stones (defined as ≥1 stone ≥15 mm or ≥3 stones each ≥10 mm on imaging)
  • Ability to provide informed consent (or via legal representative).

You may not qualify if:

  • Contraindications to ERCP or general anesthesia
  • History of biliary surgery or altered anatomy
  • Benign or malignant strictures of the distal CBD
  • Intrahepatic bile duct stones
  • Moderate to severe cholangitis
  • Malignancy or serious condition with life expectancy \<6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Liver Institute, Menoufia University, Egypt.

Shebeen El-Kom, Monufia Governorate, 32511, Egypt

Location

Related Publications (4)

  • Tonozuka R, Itoi T, Sofuni A, Itokawa F, Kurihara T, Tsuchiya T, Ishii K, Tsuji S, Ikeuchi N, Umeda J, Tanaka R, Honjyo M, Mukai S, Fujita M, Moriyasu F. Efficacy and safety of endoscopic papillary large balloon dilation for large bile duct stones in elderly patients. Dig Dis Sci. 2014 Sep;59(9):2299-307. doi: 10.1007/s10620-014-3156-9. Epub 2014 Apr 26.

    PMID: 24771320BACKGROUND
  • Kim KH, Kim TN. Efficacy and Safety of Endoscopic Papillary Large Balloon Dilation for Removal of Large Bile Duct Stones in Advanced Age. Can J Gastroenterol Hepatol. 2016;2016:6568989. doi: 10.1155/2016/6568989. Epub 2016 Oct 12.

    PMID: 27812520BACKGROUND
  • Ye X, Huai J, Sun X. Effectiveness and safety of biliary stenting in the management of difficult common bile duct stones in elderly patients. Turk J Gastroenterol. 2016 Jan;27(1):30-6. doi: 10.5152/tjg.2015.150305. Epub 2015 Dec 17.

    PMID: 26674978BACKGROUND
  • Meng K, Zhang DY, Chen DX, Liu WJ, Fang KX, Chen S, Wu L, Li MY. Large common bile duct stones in high-risk elderly patients: Immediate endoscopic stone removal or elective stone removal? A single-center retrospective study. BMC Gastroenterol. 2023 Oct 5;23(1):344. doi: 10.1186/s12876-023-02976-0.

    PMID: 37798726BACKGROUND

MeSH Terms

Conditions

CholedocholithiasisJaundice, Obstructive

Interventions

Cholangiopancreatography, Endoscopic Retrograde

Condition Hierarchy (Ancestors)

Common Bile Duct DiseasesBile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesCholelithiasisJaundiceHyperbilirubinemiaPathologic ProcessesPathological Conditions, Signs and SymptomsSkin ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

CholangiographyRadiography, AbdominalRadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, Digestive SystemEndoscopy, Digestive SystemEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Omkolsoum Alhaddad, M.D.

    National Liver Institute, Menoufia University Egypt.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Hepatology and Gastroenterology

Study Record Dates

First Submitted

April 21, 2025

First Posted

April 29, 2025

Study Start

February 1, 2022

Primary Completion

March 1, 2024

Study Completion

September 1, 2024

Last Updated

May 6, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

There is no plan to share IPD for this study due to ethical and regulatory considerations, as well as the absence of a data-sharing infrastructure at our institution.

Locations